会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明授权
    • Folding headrest closeout member
    • 折叠头枕关闭成员
    • US08814270B2
    • 2014-08-26
    • US13524860
    • 2012-06-15
    • Grant AdamsRandy EschelbachJason GrayDale JungAnthony Spagnuolo
    • Grant AdamsRandy EschelbachJason GrayDale JungAnthony Spagnuolo
    • A47C1/10
    • B60N2/859
    • Folding assemblies for vehicles are described. In one aspect, a folding headrest assembly for a vehicle seat comprises a headrest having a frame. A pivot joint is coupled to the frame for rotatably supporting the headrest with respect to the vehicle seat between an upright position and a folded position. A support rod extends from the pivot joint and is configured for coupling to the vehicle seat. The headrest receives the pivot joint and a portion of the support rod, and the headrest defines an opening configured to provide clearance for the support rod as the headrest is rotated about the pivot joint relative to the support rod. A closeout member coupled to the support rod circumscribes at least an exposed portion of the pivot joint that is aligned with the opening of the headrest.
    • 描述车辆的折叠组件。 一方面,一种用于车辆座椅的折叠头枕组件包括具有框架的头枕。 枢转接头联接到框架,用于在直立位置和折叠位置之间相对于车辆座椅可旋转地支撑头枕。 支撑杆从枢转接头延伸并且构造成用于联接到车辆座椅。 头枕接收枢转接头和支撑杆的一部分,并且头枕限定了一个开口,该开口构造成当头枕相对于支撑杆围绕枢转接头旋转时为支撑杆提供间隙。 耦合到支撑杆的闭合构件至少围绕与头枕的开口对准的枢转接头的暴露部分。
    • 10. 发明授权
    • Crystalline polymorphs of clopidogrel
    • 氯吡格雷的结晶多晶型物
    • US07897613B2
    • 2011-03-01
    • US10571419
    • 2004-09-09
    • Ramakrishnan ArulAjay Singh RawatMaheshkumar GadakarRajesh RaoAbhinay PiseJason Gray
    • Ramakrishnan ArulAjay Singh RawatMaheshkumar GadakarRajesh RaoAbhinay PiseJason Gray
    • C07D495/04A61K31/4365A61P7/02
    • C07D495/04
    • The present invention relates to novel crystalline forms of the platelet aggregation inhibitor (+)-(S)-methyl-2-(2-chlorophenyl)-(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate, clopidogrel (1), in the form of hydrogen bromide salts, identified as polymorph forms 1, 2 and 3. The present invention further relates to processes for preparing such forms, pharmaceutical compositions comprising such forms, and uses for such forms and compositions. The pharmaceutical compositions may be used, in particular, for inhibiting platelet aggregation or for treating, preventing or managing thrombosis, atherothrombosis, an atherothrombotic event, ischaemic stroke, myocardial infarction, non-Q-wave myocardial infarction, atherosclerosis, peripheral arterial disease, or unstable angina. The present invention also relates to methods of treating said disorders. Formula (1).
    • 本发明涉及血小板聚集抑制剂(+) - (S) - 甲基-2-(2-氯苯基) - (6,7-二氢-4H-噻吩并[3,2-c]吡啶-3-基) (1),以溴化氢的形式,被鉴定为多晶型形式1,2和3.本发明还涉及制备这些形式的方法,包含这些形式的药物组合物和用于 这种形式和组成。 药物组合物可特别用于抑制血小板聚集或治疗,预防或控制血栓形成,动脉粥样硬化血栓形成,动脉粥样硬化血栓形成事件,缺血性中风,心肌梗塞,非Q波心肌梗塞,动脉粥样硬化,外周动脉疾病或 不稳定型心绞痛 本发明还涉及治疗所述疾病的方法。 公式1)。